Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Jiangsu Hansoh Pharmaceutical Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$15.9

2024-07-02

Market Capitalization

$94.9 B

2024-07-02

Revenue

¥10.1 B

FY, 2023

CreditSafe Score

?
Score changed on Jul 25, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue7.7B8.7B8.7B9.9B9.4B10.1B
Cost of goods sold523.3M528.0M568.3M591.6M522.4M664.5M
Gross profit7.3B8.2B8.2B9.5B9.0B9.5B
Gross profit margin, %94.0%94.4%94.1%95.4%95.7%94.5%
Operating expense total4.8B5.2B5.1B6.2B5.8B6.3B
Depreciation and amortization156.3M201.6M233.3M278.5M344.6M366.4M
EBITDA2.5B3.0B3.1B3.3B3.1B3.2B
EBITDA margin, %31.8%34.9%35.3%33.4%33.3%31.7%
EBIT2.3B2.8B2.9B3.0B2.6B2.7B
EBIT margin, %29.6%32.4%33.1%29.8%27.4%26.5%
Interest income2.9M153.6M92.0M164.1M309.1M905.0M
Interest expense123.0K1.6M52.8M58.1M66.7M
Pre tax profit2.3B3.0B3.1B3.3B2.9B3.8B
Income tax expense406.3M444.2M529.4M587.2M364.7M488.7M
Net Income1.9B2.6B2.6B2.7B2.6B3.3B

Footer menu